Lellouche Nicolas, Berthier Romain, Mekontso-Dessap Armand, Braconnier François, Monin Jean-Luc, Duval Anne-Marie, Dubois-Randé Jean Luc, Guéret Pascal, Garot Jérôme
Fédération de Cardiologie, Hôpital de Jour, Henri Mondor University Hospital, Créteil, France.
Am J Cardiol. 2005 Jun 1;95(11):1380-2. doi: 10.1016/j.amjcard.2005.01.090.
After successful external cardioversion, the rate of recurrence of atrial fibrillation remains high. The hypothesis that plasma B-type natriuretic peptide could predict the recurrence of atrial fibrillation at 1 year was tested. Plasma B-type natriuretic peptide was measured in 66 consecutive asymptomatic patients who underwent external cardioversion for atrial fibrillation. Twelve-lead electrocardiograms were obtained at 1 year. Sinus rhythm was maintained in 55% of patients. The independent predictors of the recurrence of atrial fibrillation at 1 year were a history of atrial fibrillation, plasma B-type natriuretic peptide, and the energy delivered for conversion. In patients without symptoms of heart failure, plasma B-type natriuretic peptide is an independent predictor of the recurrence of atrial fibrillation.
成功进行体外心脏复律后，房颤复发率仍然很高。对血浆B型利钠肽能否预测房颤1年复发率的假设进行了检验。对66例因房颤接受体外心脏复律的连续无症状患者测定了血浆B型利钠肽。1年后获得12导联心电图。55%的患者维持窦性心律。房颤1年复发的独立预测因素为房颤病史、血浆B型利钠肽以及复律时传递的能量。在没有心力衰竭症状的患者中，血浆B型利钠肽是房颤复发的独立预测因素。
